Abstract
The coexistence of a complete mole and an alive fetus is a rare condition that can evolve with multiple complications both maternal and fetal; among them abortion, preeclampsia, hyperthyroidism, uterine bleeding, preterm labor and persistent gestational trophoblastic disease. There is no international consensus regarding the management of this condition, despite the poor prognosis for the fetus and the associated high maternal risks. The following is a report of a clinical case of twin pregnancy with live fetus and complete mole, diagnosed at 12+1 weeks. After counseling, and in the context of Chilean legislation in 2015, it is decided to continue with pregnancy. The patient is monitored in a high-risk pregnancy outpatient clinic with follow ups b-HCG, fetal ultrasound and pelvic MRI. From 13 weeks, the patient presents high blood pressure that is managed with oral antihypertensives; and later, with 20+2 weeks, developed severe preeclampsia which is why, in conjunction with patient, it was decided to perform a block hysterectomy. Given the persistence of elevated b-HCG values at 12 weeks post-termination of pregnancy, treatment with methotrexate was decided. The case was analyzed in the local Committee of Oncological Gynecology, in which it was decided to follow the b-HCG curve, achieving negative values at 38 weeks post-methotrexate. Negative values of b-HCG were confirmed for 6 months, after which it was discharged.
Cite
CITATION STYLE
Ravello, G. I., Sáez, C. J., Poblete, V. A., Altamirano, R., & Solari, D. M. (2019). Reporte de un caso: Embarazo gemelar con un feto vivo y mola completa. Revista Chilena de Obstetricia y Ginecologia, 84(2), 136–141. https://doi.org/10.4067/S0717-75262019000200136
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.